FDA Inspection
Georgia Eye Bank, Inc.Georgia Eye Bank, Inc. – FDA Inspection, Apr 30, 2026
Record Details
This FDA Inspection record concerns Georgia Eye Bank, Inc., with an inspection on April 30, 2026, issued by the Atlanta District Office, covering biologics.
View Company Profile
ID · 6c762128-4a3a-4c7f-9746-3d5d4e7dd2b6
Inspection Facts
- Inspection number
- 1314808
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.160(b)(6)Deviations--Investigation, documenting, trending
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Georgia Eye Bank, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 8, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 24, 2019 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 28, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 19, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 1, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Georgia Eye Bank, Inc.
- FDA Inspection 1192021 - 2022-11-08
- FDA Inspection 1090641 - 2019-05-24
- FDA Inspection 1028414 - 2017-09-28
- FDA Inspection 938757 - 2015-08-19
- FDA Inspection 829797 - 2013-05-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.